Will a New Jersey drug maker fill the gap left by a shuttered Lehigh County pharmacy? It says it wants a site in Allentown
Quva Pharma says it wants an Allentown site after buying a group of medicines formerly made by CAPS.

See the story visuallyQuva Pharma’s Allentown plan
Visual summary
Allentown under consideration
Quva says it is in early talks with property owners and has not named a location.
CAPS products acquired
Quva bought a group of medicines from Central Admixture Pharmacy Services.
Want the full context? Read the article ↓
GREENWICH TOWNSHIP, N.J. (Nov. 13, 2026) — A drug company says it wants to open a site in Allentown. It is taking over medicines that a Lehigh County pharmacy used to make.
Quva Pharma told WFMZ it wants to make some drugs in Allentown. It also wants to store and ship its medicines there.
The company is in early talks with property owners, a spokesperson said. It is too early to name a location.
In September, Quva said it bought a group of medicines from Central Admixture Pharmacy Services, or CAPS. CAPS is part of B. Braun. It has left the business of making these drugs.
CAPS had two of these drug plants. One was in Upper Macungie Township in Lehigh County. The other was in Phoenix, Arizona.
These plants are called 503B pharmacies. They make big batches of germ-free drugs. They sell them to hospitals and other health care sites. Other pharmacies make drugs for one patient at a time.
The CAPS exit worried the Food and Drug Administration, or FDA. The agency said hospitals could run short of IV food for newborns once the CAPS plants closed.
These IV products feed babies who are born early or are very sick. The babies cannot eat by mouth or through a feeding tube.
In early September, before Quva's deal was announced, the FDA eased some rules for making these products.
Quva is based in Sugar Land, Texas. It has plants in Texas and in Greenwich Township, New Jersey, near Bloomsbury.
The company is now moving the CAPS products to its New Jersey plant, the spokesperson said.
The spokesperson said in an email that it is a hard process. The spokesperson said B. Braun, CAPS and the FDA are helping a lot.
"We have recruited 36 staff from the CAPS business as part of this process," the spokesperson said.
Quva expects its first batch of these drugs to go into hospitals in early 2027.
First, it will focus on six IV food mixes for newborns, the company said. It will also make four cardioplegia products, which are used in heart surgery, and two heparin products.
Your reaction
Want more Lehigh Valley news in your Google results? Add Yooumad as a preferred source.



What do you think?
Join the conversation. A nickname is optional; comments are reviewed for spam and safety.